Next Generation Pneumococcal Vaccines: What You Need to Know
| Overview / Abstract: |
What’s new with pneumococcal vaccines? In 2021, two exciting, next-generation pneumococcal vaccines have become available. Expert faculty from Loma Linda University, the University of Pittsburgh School of Medicine, and the Lewis Katz School of Medicine at Temple University recently led a symposium at a major internal medicine meeting outlining the characteristics and latest recommendations with these novel vaccines. Learn how to overcome present barriers with vaccine uptake (particularly amidst the ongoing COVID-19 pandemic), and the key serotypes most responsible for invasive pneumococcal disease. Don’t throw away your shot! View these important highlights. UPDATE 6/22/22: PCV15 is now also approved for children 6 weeks through 17 years of age. |
|
Expiration |
May 27, 2023 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
|
Format |
Online |
|
Credits / Hours |
1.0 AMA PRA Category 1 Credit™; 1.0 contact hour |
|
Accreditation |
ACCME, ACPE |
|
Presenters / Authors / Faculty |
Michael Hogue, PharmD, FAPhA, FNAP; Donald Middleton, MD; Margot Savoy, MD, MPH, FAAFP |
|
Sponsors / Supporters / Grant Providers |
This activity is supported through an Independent Medical Education grant from Merck & Co., Inc.. |
|
Keywords / Search Terms |
ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Webcasts, Newsletter, Case Study, Live Meetings, Slidekit, Monograph, Journal, CME, CE, Continuing Medical Education, CME/CE, Online Learning, Live Meeting, Symposium, CME, Michael Hogue, Donald Middleton, Margaret Savoy, pneumococcal, vaccine, patient access, reimbursement, Medicare, case study, COVID, COVID-19, Streptococcus pneumoniae, serotype, PCV15, PCV20 Free CE CME |
|